BioCentury
ARTICLE | Financial News

Xenogen amends IPO

June 15, 2004 7:00 AM UTC

In vivo imaging company Xenogen (Alameda, Calif.) amended its proposed IPO and now hopes to sell 3.5 million shares at $9-$11. A $10 price would raise $35 million and value the company at $139.8 milli...